L'Oréal S.A. (EPA:OR)
France · Delayed Price · Currency is EUR | Market Cap | 204.78B +2.5% |
| Revenue (ttm) | 45.35B +3.5% |
| Net Income | 6.31B +3.0% |
| EPS | 11.78 +3.2% |
| Shares Out | 532.39M |
| PE Ratio | 32.66 |
| Forward PE | 26.97 |
| Dividend | 7.20 (1.89%) |
| Ex-Dividend Date | Apr 29, 2026 |
| Volume | 100,149 |
| Open | 384.05 |
| Previous Close | 384.65 |
| Day's Range | 380.75 - 387.20 |
| 52-Week Range | 338.85 - 405.80 |
| Beta | 0.89 |
| Analysts | Buy |
| Price Target | 417.75 (+9.65%) |
| Est. Earnings | Oct 20, 2026 |
About L'Oréal
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men in Europe, North America, North Asia, South Asia Pacific, the Middle East, North Africa, Sub-Saharan Africa, and Latin America. It operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. The company offers skincare, make-up, hair colourant, haircare, perfume, and hygiene products. It provides its products under the L’Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, ... [Read more]
Financial Performance
In 2025, L'Oréal's revenue was 44.05 billion, an increase of 1.30% compared to the previous year's 43.49 billion. Earnings were 6.13 billion, a decrease of -4.39%.
Financial StatementsAnalyst Summary
According to 24 analysts, the average rating for OR stock is "Buy." The 12-month stock price target is €417.75, which is an increase of 9.65% from the latest price.
News
Are luxury stocks in trouble?
The household goods sector has had a whirlwind week, with Bernstein raising its rating for Moncler and Barclays cutting price target for LVMH. Meanwhile, L'Oreal briefly took over LVMH as France's mos...
L'Oreal steals French stock market crown from LVMH
Cosmetics group L'Oreal became France's most valuable listed company on Tuesday, surpassing Louis Vuitton owner LVMH as high-end luxury companies remain under pressure after years of slowing sa...
L’Oreal sued by Arizona for allegedly hiding cancer risk, Reuters says
L’Oreal (LRLCY) and its U.S. subsidiary have been sued by Arizona Attorney General Kristin Mayes, alleging the company hid evidence that its hair relaxer products could cause cancer in women,…
Arizona accuses L'Oreal of concealing cancer risks linked to hair relaxers
Arizona has sued L'Oreal SA , alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer in women, as it faces thousands of similar lawsuits from users and their fa...
L'Oréal Transcript: Barclays 19th Annual Global Consumer Conference
The conference introduced luxury, leisure, and retail to its agenda, with record participation. Strong H1 growth was driven by innovation, premiumization, and e-commerce, with standout performance in SAPMENA and China. Strategic focus remains on R&I, AI, M&A, and operational efficiencies.
L'Oréal Slides: Barclays 19th Annual Global Consumer Conference
L'Oréal has posted slides in relation to its latest quarterly earnings report, which was published on September 8, 2026.
L’Oreal upgraded to Outperform from Neutral at BNP Paribas
BNP Paribas analyst Jeff Stent upgraded L’Oreal (LRLCY) to Outperform from Neutral with a EUR 460 price target
L’Oreal price target lowered to $100 from $110 at Argus
Argus analyst John Staszak lowered the firm’s price target on L’Oreal (LRLCY) to $100 from $110 and keeps a Buy rating on the shares. Revenue growth is normalizing as the…
L’Oreal price target raised to EUR 375 from EUR 365 at JPMorgan
JPMorgan raised the firm’s price target on L’Oreal (LRLCY) to EUR 375 from EUR 365 and keeps a Neutral rating on the shares.
L’Oreal upgraded to Hold from Underperform at Jefferies
Jefferies upgraded L’Oreal (LRLCY) to Hold from Underperform with a price target of EUR 377, up from EUR 328. The firm cites the company’s improving sales growth post the Q2…
L’Oreal price target raised to EUR 388 from EUR 376 at Morgan Stanley
Morgan Stanley raised the firm’s price target on L’Oreal (LRLCY) to EUR 388 from EUR 376 and keeps an Equal Weight rating on the shares.
L'Oreal to launch first Gucci beauty products as early as 2028, CEO says
L'Oreal plans to launch its first Gucci beauty products as early as 2028, the company's Chief Executive Nicolas Hieronimus said on Thursday, adding he was "super ambitious" for the brand that i...
L'Oréal Earnings Call Transcript: H1 2026
Strong first-half results with 6.5% like-for-like growth, record margins, and robust cash flow, driven by innovation, e-commerce, and strong regional and segment performance. Confident outlook for H2, supported by new launches, acquisitions, and continued digital transformation.
L'Oréal Earnings release: H1 2026
L'Oréal released its H1 2026 earnings on July 30, 2026, summarizing the period's financial results.
L'Oréal Slides: H1 2026
L'Oréal has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 30, 2026.
L'Oréal Quarterly report: H1 2026
L'Oréal has published its H1 2026 quarterly earnings report on July 30, 2026.
L'Oreal sales rise on haircare boom and 'lipstick effect'
The world's largest cosmetics company L'Oreal reported better-than-expected quarterly sales on Wednesday, boosted by strong demand for new hair products and mascaras.
L’Oreal reports Q1 sales EUR 12.15B, up 3.6% reported and 7.6% LFL
Adjusted like-for-like growth was +6.7%. Commenting on the figures, Nicolas Hieronimus, CEO of L’Oreal (LRLCY), said:”L’Oreal is off to a great start with adjusted like-for-like growth1 of +6.7%. We n...
L’Oreal reports 1H sales EUR 23.77B
12:01 EDT L’Oreal (LRLCY) reports 1H sales EUR 23.77B
L'Oreal posts 6% rise in quarterly sales
L'Oreal reported a 6.3% rise in second-quarter sales on Wednesday, slightly higher than expected, driven by strong demand for its premium haircare as well as mass market brands.
From shampoo to cookies, consumer products get an AI makeover
French cosmetics company L'Oreal has used AI to identify molecules in its skincare products that can be repurposed for use in shampoo and can now create products four times faster than before, a seni...
L’Oreal price target raised to EUR 376 from EUR 375 at Morgan Stanley
Morgan Stanley raised the firm’s price target on L’Oreal (LRLCY) to EUR 376 from EUR 375 and keeps an Equal Weight rating on the shares.
L’Oreal upgraded to Buy from Neutral at Citi
Citi upgraded L’Oreal (LRLCY) to Buy from Neutral with a price target of EUR 435, up from EUR 375. The firm sees the integration and ramp-up of Kering Beauty driving…
L’Oreal downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank last night downgraded L’Oreal (LRLCY) to Sell from Hold with a price target of EUR 340, down from EUR 360. The firm expects the company’s growth to slow…
L’Oreal downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Tom Sykes downgraded L’Oreal (LRLCY) to Sell from Hold with a EUR 340 price target